<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HA2D95551D1BD4721A08DA8A6ADEB93D7" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 2545 IH: Special Diabetes Program for Indians Reauthorization Act of 2017 </dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-05-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 2545</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20170518">May 18, 2017</action-date><action-desc><sponsor name-id="T000474">Mrs. Torres</sponsor> (for herself, <cosponsor name-id="Y000033">Mr. Young of Alaska</cosponsor>, <cosponsor name-id="C001053">Mr. Cole</cosponsor>, <cosponsor name-id="L000578">Mr. LaMalfa</cosponsor>, and <cosponsor name-id="M001143">Ms. McCollum</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To reauthorize the special diabetes programs for Indians.</official-title></form>
	<legis-body id="HB8AFC7DA99594E7D8441EAE840721D8E" style="OLC">
 <section id="H8010A1094A4548B7A97EDA191F9CA659" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Special Diabetes Program for Indians Reauthorization Act of 2017 </short-title></quote>.</text> </section><section id="H692E615B9EA9401CB3CF5D35823368FE"><enum>2.</enum><header>Findings</header><text display-inline="no-display-inline">Congress finds that:</text>
 <paragraph id="H75B76DA1B9824656A1CD0BEAEED3C539"><enum>(1)</enum><text>American Indians and Alaska Natives are disproportionately affected by diabetes.</text> </paragraph><paragraph id="H4F729AD6015A459D8271B6A73BB0C2F2"><enum>(2)</enum><text>Approximately 16 percent of American Indian and Alaska Native people have diabetes compared to only 12 percent of the general United States population.</text>
 </paragraph><paragraph id="H3C41590D4D704437BA60D60FECAFF117"><enum>(3)</enum><text>The death rate due to diabetes for American Indians and Alaska Natives is 1.6 times higher than for the general population.</text>
 </paragraph><paragraph id="H3C491575C7CD4E3C9305798FE618E8DD"><enum>(4)</enum><text>In response to the growing epidemic of diabetes among Native communities, Congress authorized the Special Diabetes Programs for Indians in 1997.</text>
 </paragraph><paragraph id="HB08A816DDC724C95A55666E493DD4F15"><enum>(5)</enum><text>Since the first authorization, the Special Diabetes Programs for Indians have—</text> <subparagraph id="H7ACAE556D132430FAA2B71C462915A0D"><enum>(A)</enum><text>made it possible for Native communities to develop and sustain quality diabetes treatment and prevention programs, including—</text>
 <clause id="H04AF0C443A1B47B8B005AA862089C782"><enum>(i)</enum><text>a 40-percent increase in number of diabetes clinics;</text> </clause><clause id="HAD80273BF5184FE2AC24A4947DBA756F"><enum>(ii)</enum><text>a 42-percent increase in access to registered nutritionists; and</text>
 </clause><clause id="H002231A1760745ADBEEB1FC263A8EB5F"><enum>(iii)</enum><text>a 61-percent increase in availability of culturally tailored education programs;</text> </clause></subparagraph><subparagraph id="H24E30726D71647FCBCBAB7215EF71318"><enum>(B)</enum><text>resulted in concrete health outcomes, like a 48-percent decrease in end-stage renal disease among American Indian and Alaska Native populations; and</text>
 </subparagraph><subparagraph id="H6B3154C4B8394BA28F035E139C4E0AE7"><enum>(C)</enum><text>led to millions of dollars in healthcare cost savings by decreasing the prevalence of costly preventable diabetes complications.</text>
 </subparagraph></paragraph><paragraph id="HA1306D4A3037423B8DF5D709F36DD796"><enum>(6)</enum><text>Due to the continued positive impact of the Special Diabetes Programs for Indians on Native communities and the large return on investment for healthcare funding, Congress has shown its support for the programs by—</text>
 <subparagraph id="H26D1626E199040028963948D6D524002"><enum>(A)</enum><text>reauthorizing the Special Diabetes Programs for Indians no less than 8 times; and</text> </subparagraph><subparagraph id="HE257607A92CC4946A2E49935AD5F5816"><enum>(B)</enum><text>sending letters of support for the Special Diabetes Programs to Congressional leadership signed by more than 350 Representatives and 75 Senators.</text>
 </subparagraph></paragraph></section><section id="H0BAFDAEF23724B6FA99AD860991A85CF"><enum>3.</enum><header>Reauthorization of the special diabetes programs for indians</header><text display-inline="no-display-inline">Section 330C(c) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/254c-3">42 U.S.C. 254c–3(c)</external-xref>) is amended by striking paragraph (2) and inserting the following:</text>
			<quoted-block display-inline="no-display-inline" id="H5F7C74C30A694012BD469ECA90FF489E" style="OLC">
				<paragraph id="HA41DBECAB5EF42CD9ECA028450444B78"><enum>(2)</enum><header>Appropriations</header>
 <subparagraph id="H6E9F0709170C4AF5B67A436B3F0D27BD"><enum>(A)</enum><header>In general</header><text>For the purpose of making grants under this section, there is appropriated, out of any money in the Treasury not otherwise appropriated—</text>
 <clause id="H67051B437F724002B1312CF5D8DABF01"><enum>(i)</enum><text>$150,000,000 for fiscal year 2018; and</text> </clause><clause id="HA344C5DF18594B6BAF15F403C90A7D32"><enum>(ii)</enum><text>the amount specified in subparagraph (B) for each of fiscal years 2019 through 2024.</text>
						</clause></subparagraph><subparagraph id="H22F14300C6AA437CB0AFF29C7E0944B1"><enum>(B)</enum><header>Inflation adjustment</header>
 <clause id="HAC52C6D0EA134434A612103515EF6865"><enum>(i)</enum><header>In general</header><text>In the case of any of fiscal years 2019 through 2024, the dollar amount in subparagraph (A)(i) shall be increased by an amount equal to the product of—</text>
 <subclause id="H4B5DE0BAAF214E808D797A6AF6985182"><enum>(I)</enum><text>such dollar amount; and</text> </subclause><subclause id="H98BCEDAB74944380B737ED34234CFE9A"><enum>(II)</enum><text>the percentage increase in the medical care component of the consumer price index for the previous fiscal year as calculated by United States Bureau of Labor Statistics.</text>
 </subclause></clause><clause id="HA81EF7A6885648D7AA96CBA6F6A210EC"><enum>(ii)</enum><header>Rounding</header><text>If the amount of any increase under clause (i) is not a multiple of $10, such increase shall be rounded to the next lowest multiple of $10.</text></clause></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body></bill>


